Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8

Journal of Human Virology

Volumn 1, Issue 3, 1998, Pages 193-199

  Ariyoshi, K ^a   Schim Van Der Loeff, M ^a   Cook, P ^b   Whitby, D ^c   Corrah, T ^a   Jaffar, S ^d   Cham, F ^a   Sabally, S ^a   O'Donovan, D ^a   Weiss, R A ^c   Schulz, T F ^b   Whittle, H ^a  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

HHV 8; HIV 1; HIV 2; KS; West Africa

Indexed keywords

ADOLESCENT; ADULT; AIDS RELATED COMPLEX; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GAMBIA; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; KAPOSI SARCOMA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREGNANCY; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; VIROLOGY;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GAMBIA; HERPESVIRUS 8, HUMAN; HIV-1; HIV-2; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREGNANCY; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SARCOMA, KAPOSI;

EID: 0032009558     PISSN: 10909508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Chang Y, Cesarman E, Pessin MS, et al. Identification of Herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-1869.
2. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi's sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995;346:799-802.
3. Moore PS, Kingsley LA, Holmberg SD, et al. KSHV infection prior to onset of Kaposi's sarcoma. AIDS 1996;10: 175-180.
4. Boshoff C, Schulz TF, Kennedy MM, et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nature Med 1995;1:1274-1278.
5. Schalling M, Ekman M, Kaaya E, et al. A role for a new herpesvirus (Kaposi's sarcoma-associated herpesvirus) in different forms of KS. Nat Med 1995;1:707-708.
6. Boshoff C, Whitby D, Hatzioannou T, et al. Kaposi's sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 1995;345:1043-1044.
7. Miller G, Rigsby MO, Heston L, et al. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated Herpesvirus in patients with HIV-1 infection. N Engl J Med 1996;334:1292-1297
8. Gao SJ, Kingsley L, Hoover DR, et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996;335:233-241
9. Kedes DH, Operskalski E, Busch M, et al. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996;2:918-924
10. Gao SJ, Kingley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996;2:925-928.
11. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996;348:858-861.
12. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996;349: 1133-1138.
13. Beral V. Epidemiology of Kaposi's sarcoma. In: Beral V, Jaffe HW, Weiss RA, eds. Cancer, HIV and AIDS: cancer survival. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1991:5-22.
14. Ziegler JL. Endemic Kaposi's sarcoma in Africa and local volcanic soils. Lancet 1993;342:1348-1351.
15. Clavel F, Manshinho K, Chamaret S, et al. Human immunodeficiency virus type 2 infection associated with AIDS in West Africa. N Engl J Med 1987;316:1180-185.
16. Whittle HC, Wilkins A, Morris J, et al. Patients infected with HIV-2 survive longer than those infected with HIV-1. AIDS 1994;8:1617-1620.
17. Quinn TC, Mann JM, Curran JW, P Piot. AIDS in Africa: an epidemiologic paradigm. Science 1986;234:955-963.
18. Pepin J, Morgan G, Dunn D, et al. HIV-2-induced immunosupression among asymptomatic West African prostitutes: evidence that HIV-2 is pathogenic, but less so than HIV-1. AIDS 1991;5:1165-1172.
19. Naucler A, Albino P, Paolo Da Silva PA, et al. HIV-2 infection in hospitalized patients in Bissau, Guinea-Bissau. AIDS 1991;5:301-304.
20. Whittle H, Egboga A, Todd J, et al. Immunological responses of Gambians in relation to clinical stage of HIV-2 disease. Clin Exp Immunol 1993;93:45-50.
21. De Cock KM, Porter A, Kouadio J, et al. Rapid and specific diagnosis of HIV-1 and HIV-2 infections: an evaluation of testing strategies. AIDS 1990;4:875-878.
22. Kikuta H, Itakura O, Ariga T, Kobayashi K. High prevlance of HHV-8 DNA sequences in Japan. J Med Virol 1997;53:81-84.
23. + lymphopaenia in HIV-2 infected individuals. AIDS Res Hum Retroviruses 1994;8:1031-1037.
24. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989;339:237-238.
25. Desmond-Hellmann SD, Katongole-Mbidde E. Kaposi's sarcoma: recent developments. AIDS 1991;5(Suppl. 1):S135-S142.
26. Huang YQ, Li JJ, Kaplan MH, Poiesz E, et al. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 1995;345:759-761.
27. Zong J-C, Metroka C, Reitz HS, et al. Strain variability among Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genomes: evidence that a large cohort of United States AIDS patients may have been infected by a single common isolate. J Virol 1997;71:2505-2511.
28. Gill PS, Lunardi-Iskandar Y, Louie S, et al. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. N Engl J Med 1996;335:1261-1269.
29. Ensoli B, Gendelman R, Markham P, et al. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 1994;371: 674-680.
30. Barillari G, Gendelman R, Gallo R, Ensoli B. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc Natl Acad Sci U S A 1993;90:7941-7945.
31. Albini A, Soldi R, Giunciuglio D, et al. The angiogenesis induced by HIV-1 Tat protein is mediated by the Flk-1/ KDR receptor on vascular endothelial cells. Nat Med 1996;2:1371-1375.
32. Harrington W Jr, Sieczkowski L, Sosa C, et al. Activation of HHV-8 by HIV-1 tat. Lancet 1997;349:774-775.
33. Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990;335:123-128.
34. Van der Perre P, Rouvroy D, Lepage P, et al. Acquired immunodeficiency syndrome in Rwanda. Lancet 1984;2: 62-65.
35. Piot P, Quinn T, Taelman H, et al. Acquired immunodeficiency syndrome in a heterosexual population in Zaire. Lancet 1984;2:65-69.
36. Lifson AR, Darrow WW, Hessol NA, et al. Kaposi's sarcoma in a cohort of homosexual and bisexual men. Am J Epidemiol 1990;131:221-231.
37. Tedder RS, O'Connor T, Hughes A, et al. Envelope cross-reactivity in Western blot for HIV-1 and HIV-2 may not indicate dual infection. Lancet 1988;2:927-930.